Carole Ben-Maimon
CIK: 0001529611
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LRMR
Larimar Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About BEN-MAIMON CAROLE
BEN-MAIMON CAROLE (SEC CIK 0001529611) files insider reports with the SEC as President and CEO of Larimar Therapeutics, Inc. (LRMR).
Signal8 holds 2 ownership filings by BEN-MAIMON CAROLE, all Form 4s, filed between Jan 24, 2025 and Jan 27, 2026. Those filings report 2 transactions, from Jan 22, 2025 to Jan 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BEN-MAIMON CAROLE's filings is in BALA CYNWYD, PA.
Recent filings by BEN-MAIMON CAROLE
Other insiders filing for Larimar Therapeutics, Inc. (LRMR)
- Harlow John B. Jr., President and COO
- Hamilton Thomas Edward, Director
- Flynn James E, Director
- LEFF JONATHAN S, Director
- SHERMAN JEFFREY W, Director
- Truitt Joseph, Director